Efficacy of combined therapy with paclitaxel and low-level ultrasound in human chronic myelogenous leukemia cell line K562

Author： Yang Shuang   Wang Pan   Wang Xiaobing   Zhang Kun   Zhang Xing   Liu Quanhong  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.21, Iss.9, 2013-11, pp. : 874-884

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Myelogenous Leukemia Guidelines

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 5, 2007-05 ,pp. : 474-474

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL

By  

Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. : 530-536

Bentham Science Publishers

Access to resources Recommend Favorite

Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia

By  

Current Cancer Drug Targets, Vol. 13, Iss. 1, 2013-01 ,pp. : 69-79

Bentham Science Publishers

Access to resources Recommend Favorite

New Agents in Chronic Myelogenous Leukemia

By Cortes Jorge   Giles Francis  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 4, 2003-11 ,pp. : 501-512

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Toxicity of methylmercury conjugated with l-cysteine on rat thymocytes and human leukemia K562 cells in comparison with that of methylmercury chloride

By Oyama Y.   Yamazaki Y.   Okada Y.   Takahama K.   Satoh M.   Hayashi H.  

Environmental Toxicology and Pharmacology, Vol. 9, Iss. 1, 2000-12 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite